Syngene International appoints five executives to leadership committee

Syngene International Limited has appointed five new members to its executive committee, effective August 20, 2025.

Ajay Tandon has been appointed head of strategy and corporate development. Gaurav Kushwaha joins as chief technology officer. Dr. Mrinal Kammili takes on the role of head of translational and clinical research. Dr. Subhendu Kumar is appointed head of chemistry, and Dr. Priyaranjan Pattanaik joins as head of biology.